GSK plc (GLAXF)

Market Cap	94.01B
Revenue (ttm)	43.24B
Net Income (ttm)	7.39B
Shares Out	n/a
EPS (ttm)	1.79
PE Ratio	12.73
Forward PE	9.97
Dividend	0.82 (3.75%)
Ex-Dividend Date	Aug 14, 2025

Volume	275
Average Volume	1,004
Open	21.90
Previous Close	23.30
Day's Range	21.90 - 23.30
52-Week Range	15.54 - 23.30
Beta	n/a
RSI	55.06
Earnings Date	Oct 29, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It a...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1715
• Employees: 68,629
• Stock Exchange: OTCMKTS
• Ticker Symbol: GLAXF

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP